American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

Thumbnail

Goal Reversal? Study Suggests Echocardiography Could Have an Underuse Problem

ASE says new data may be a “wake-up call” to recognize the value of echocardiography.  

Thumbnail

ASE scientific sessions to highlight point-of-care ultrasound, strain imaging and 3D echocardiography

At the American Society of Echocardiography (ASE) annual scientific sessions, the use of point-of-care echocardiography is among the major topics of discussion. The conference takes place from June 12 to June 16 at the Hynes Convention Center in Boston.

Q&A: Contrast for Stress Echo

ASE members discuss recent changes to contrast enhanced stress echo.

ASE, GE partner in India for cardiovascular ultrasound training

The American Society of Echocardiography (ASE) and GE Healthcare have teamed to provide a cardiovascular ultrasound training event for healthcare providers caring for underserved populations in rural northwest India.

ASE: Are cardiovascular sonographers at high risk of radiation exposure?

There is growing concern among cardiac sonographers about the amount of radiation exposure they experience on the job and few say their workplace has a formal policy to address radiation safety for sonographers, according to a survey conducted by the American Society of Echocardiography.

New ASE guidelines offer clarity for right ventricular assessment

The American Society of Echocardiography (ASE) has published new guidelines to improve the existing norms of the right heart in the July issue of the Journal of the American Society of Echocardiography. The recommended procedures will establish a more uniform method of evaluating the size and function of the right ventricle, said the society.

ASE: Biomarkers may predict chemo-related cardiotoxicity

According to research presented during the 21st annual scientific sessions of the American Society of Echocardiography (ASE) in San Diego this week, cardiac troponin plasma concentrations and longitudinal strain can predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab chemotherapies.

ASE recommends contrast agent usage in echoes

The American Society of Echocardiography (ASE) has issued a consensus statement, supporting the use of contrast agents used to enhance echocardiogram images, and providing a guide for physicians who may be hesitant to use the contrast agents following a 2007 FDA black-box warning. The statement was published in the November issue of Journal of the American Society of Echocardiography.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup